Atai stocks.
(See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ...
35,390.15 +117.12(+0.33%) Nasdaq -15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM -...1.47M. 111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...Oct 24, 2023 · Mind Medicine Inc. ( MNMD) MindMed shares are down by 38.7% over the past three months, but they are up 23.2% year to date as of Oct. 24. The New York-based company specializes in the development ... The upgrade of atai Life Sciences N.V. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...ATAI Life Sciences N.V. Common Shares (ATAI) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price...
With its shares down by 60% in the last 12 months and a recent layoff affecting 30% of its workforce, it's fair to say that Atai Life Sciences ( ATAI 1.87%) is having a rough go of things lately ...
Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …
ATAI stock, a health technology company in the pharmaceutical industry, had a mixed performance on November 21, 2023, according to data from CNN Money. The stock opened at $1.10 and traded within a narrow range of $1.09 to $1.11. The trading volume was relatively low at 18,798 shares. ATAI has a market capitalization of $182.6 million.ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian …View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Find the latest Insider Activity data for ATAI Life Sciences N.V. Common Shares (ATAI) at Nasdaq.com.
PONGF | Complete Atari S.A.S. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Mar 6, 2023 · Atai Life Sciences (NASDAQ: ATAI) just announced it has laid off roughly 30% of its staff. Shares are rising today, but it’s been a very difficult year for this penny stock. After declining more ...
According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price.(NASDAQ: ATAI) Atai Life Sciences Nv stock price per share is $1.17 today (as of Nov 10, 2023).Find the latest Jet.AI Inc. (JTAI) stock quote, history, news and other vital information to help you with your stock trading and investing.ATAI Life Sciences N.V. analyst estimates, including ATAI earnings per share estimates and analyst recommendations.Mar 31, 2023 · Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...
Nov 30, 2023 · ATAI Life Sciences NV’s trailing 12-month revenue is $0.3 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.317 per share for the current fiscal year. ATAI Life Sciences NV does not currently pay a dividend. Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comView the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.1. Atai Life Sciences. With prominent backing from venture capitalists, including billionaire Peter Thiel, it’s not surprising that Atai Life Sciences ranks as one of the biggest biotech stocks ...ATAI stock, a health technology company in the pharmaceutical industry, had a mixed performance on November 21, 2023, according to data from CNN Money. The stock opened at $1.10 and traded within a narrow range of $1.09 to $1.11. The trading volume was relatively low at 18,798 shares. ATAI has a market capitalization of $182.6 million.
The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...
intraday 1w 1m 6m ytd 1y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10...The latest price target for ATAI Life Sciences (NASDAQ: ATAI) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price ...Atai Life Sciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,630,000 shares, an increase of 20.6% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...In January 2023, atai announced results from the Phase 2a proof-of-concept study evaluating a single IV administration of PCN-101 in patients with treatment-resistant depression across three arms ...1.47M. 111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... Jan 8, 2023 · What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focuses on long-term growth and risk management. Pros and cons to owning his top 5 stocks. Apr 6, 2022 · Atai already has an MDMA-derived drug in its pipeline, EMP-01, in collaboration with Empath Bio. If the FDA approves MDMA, it will help Atai as it will further interest and investments into the ...
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks Dividend yield The ratio of annual dividend to current …
Pros and cons to owning his top 5 stocks. ... Atai, I find to be very interesting and I could see them being the blueprint for almost like a VC model of how to do psychedelic drug development ...
According to 6 analyst offering 12-month price targets in the last 3 months, ATAI Life Sciences has an average price target of $15.33 with a high of $23.00 and a low of $9.00. Below is a summary ...The upgrade of atai Life Sciences N.V. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...On average, Wall Street analysts predict. that Atai Life Sciences Nv's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10.Consolidated Financial Results. Cash, Cash Equivalents, and Short-term investments: Cash, cash equivalents and short-term investments totaled $209.0 million as of September 30, 2023, compared to ...ATAI is down -$0.02 from the previous closing price of $1.14 on volume of 308,405 shares. Over the past year the S&P 500 has risen 15.21% while ATAI is down -62.79%. ATAI lost -$0.46 per share in the over the last 12 months. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health ...atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...
The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.055893, which would represent a -2.23% loss compared to the current price. In the next week, the price of ATAI is expected to decrease by -18.90% and hit $ 0.875911. As far as the long-term Atai Life Sciences N.V. stock forecast is ...On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until …ATAI Life Sciences N.V. Common Shares (ATAI) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price... Instagram:https://instagram. michael van de poppetfra accountszip sharebest gold miner etf ATAI stock closed at $2.19 and is up $0.18 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a roughly average overall score of 60 meaning the stock holds a better value than 60% of stocks at its current price. best prop trading firmautozomne You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the ... insider trading benzinga All 39 ARKG ETF Holdings. The portfolio of Cathie Wood updated daily. These are the positions, trades, and weight of all companies in her ARKG Genomic Revolution ETF. Search tickers or categories... Trader's Guide 2024 Ships December 21st.WebThe upgrade of atai Life Sciences N.V. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...